Centurion to provide correctional healthcare in New Mexico

Cara Livernois | | Health Exec | Precision Medicine

Centurion Correctional Healthcare of New Mexico, a joint venture between Centene Corporation and MHM Services Inc., has been contracted by the State of New Mexico Corrections Department to provide correctional medical healthcare services and pharmacy services to more than 7,000 offenders throughout the state.    

This agreement in New Mexico marks the seventh state-wide correctional contract for Centurion, other states include Florida, Massachusetts, Minnesota, Mississippi, Tennessee and Vermont. Services are expected to start being offered in June, and the contract is scheduled for a one-year term, with three additional one-year renewal options. 

"Centurion looks forward to working with the dedicated professionals in the New Mexico Corrections Department. We recognize the importance of providing appropriate care while maintaining sound financial discipline on behalf of the State and its residents," said Steven H. Wheeler, CEO of Centurion.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.